To further examine the relationship between the methylation profile with patient characteristics and tumor markers, we focused on the 4 genes (RASSF1A, RARβ2, CDH13 and SFRP1) that showed the highest relative changes in tissue methylation status across the 65 tissue pairs. Here, CDH13 is linked to neoplasm.